These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

299 related items for PubMed ID: 9918591

  • 1. Effects of alpha-2 adrenoceptor agonists and antagonists on circling behavior in rats with unilateral 6-hydroxydopamine lesions of the nigrostriatal pathway.
    Chopin P, Colpaert FC, Marien M.
    J Pharmacol Exp Ther; 1999 Feb; 288(2):798-804. PubMed ID: 9918591
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Treadmill exercise suppresses nigrostriatal dopaminergic neuronal loss in 6-hydroxydopamine-induced Parkinson's rats.
    Yoon MC, Shin MS, Kim TS, Kim BK, Ko IG, Sung YH, Kim SE, Lee HH, Kim YP, Kim CJ.
    Neurosci Lett; 2007 Aug 09; 423(1):12-7. PubMed ID: 17644250
    [Abstract] [Full Text] [Related]

  • 6. Neuroprotective effects of the alpha2-adrenoceptor antagonists, (+)-efaroxan and (+/-)-idazoxan, against quinolinic acid-induced lesions of the rat striatum.
    Martel J, Chopin P, Colpaert F, Marien M.
    Exp Neurol; 1998 Dec 09; 154(2):595-601. PubMed ID: 9878194
    [Abstract] [Full Text] [Related]

  • 7. Noradrenergic lesion of the locus coeruleus increases apomorphine-induced circling behavior and the firing activity of substantia nigra pars reticulata neurons in a rat model of Parkinson's disease.
    Wang Y, Zhang QJ, Liu J, Ali U, Gui ZH, Hui YP, Chen L, Wu ZH, Li Q.
    Brain Res; 2010 Jan 15; 1310():189-99. PubMed ID: 19896932
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Increased behavioral response to dopaminergic stimulation of the subthalamic nucleus after nigrostriatal lesions.
    Mehta A, Thermos K, Chesselet MF.
    Synapse; 2000 Sep 15; 37(4):298-307. PubMed ID: 10891867
    [Abstract] [Full Text] [Related]

  • 10. Rats with unilateral median forebrain bundle, but not striatal or nigral, lesions by the neurotoxins MPP+ or rotenone display differential sensitivity to amphetamine and apomorphine.
    Sindhu KM, Banerjee R, Senthilkumar KS, Saravanan KS, Raju BC, Rao JM, Mohanakumar KP.
    Pharmacol Biochem Behav; 2006 Jun 15; 84(2):321-9. PubMed ID: 16820197
    [Abstract] [Full Text] [Related]

  • 11. Evidence for co-release of noradrenaline and dopamine from noradrenergic neurons in the cerebral cortex.
    Devoto P, Flore G, Pani L, Gessa GL.
    Mol Psychiatry; 2001 Nov 15; 6(6):657-64. PubMed ID: 11673793
    [Abstract] [Full Text] [Related]

  • 12. Alpha2-adrenoceptor modulation of cortical acetylcholine release in vivo.
    Tellez S, Colpaert F, Marien M.
    Neuroscience; 1999 Nov 15; 89(4):1041-50. PubMed ID: 10362293
    [Abstract] [Full Text] [Related]

  • 13. The unilateral 6-OHDA rat model of Parkinson's disease revisited: an electromyographic and behavioural analysis.
    Metz GA, Tse A, Ballermann M, Smith LK, Fouad K.
    Eur J Neurosci; 2005 Aug 15; 22(3):735-44. PubMed ID: 16101755
    [Abstract] [Full Text] [Related]

  • 14. Reformation of the nigrostriatal pathway by fetal dopaminergic micrografts into the substantia nigra is critically dependent on the age of the host.
    Bentlage C, Nikkhah G, Cunningham MG, Björklund A.
    Exp Neurol; 1999 Sep 15; 159(1):177-90. PubMed ID: 10486186
    [Abstract] [Full Text] [Related]

  • 15. Substantia nigra glutamate antagonists produce contralateral turning and basal ganglia Fos expression: interactions with D1 and D2 dopamine receptor agonists.
    McPherson RJ, Marshall JF.
    Synapse; 2000 Jun 01; 36(3):194-204. PubMed ID: 10819899
    [Abstract] [Full Text] [Related]

  • 16. Sleeping times evoked by alpha adrenoceptor agonists in two-day-old chicks: an experimental model to evaluate full and partial agonists at central alpha-2 adrenoceptors.
    Roach AG, Doxey JC, Strachan DA, Cavero I.
    J Pharmacol Exp Ther; 1983 Nov 01; 227(2):421-8. PubMed ID: 6138427
    [Abstract] [Full Text] [Related]

  • 17. Synergism of NBQX with dopamine agonists in the 6-OHDA rat model of Parkinson's disease.
    Löschmann PA, Kunow M, Wachtel H.
    J Neural Transm Suppl; 1992 Nov 01; 38():55-64. PubMed ID: 1491248
    [Abstract] [Full Text] [Related]

  • 18. Serotonergic influence on the potentiation of D-amphetamine and apomorphine-induced rotational behavior by the alpha2-adrenoceptor antagonist 2-methoxy idazoxan in hemiparkinsonian rats.
    Srinivasan J, Schmidt WJ.
    J Neural Transm (Vienna); 2005 Sep 01; 112(9):1223-36. PubMed ID: 15614426
    [Abstract] [Full Text] [Related]

  • 19. Effect of acupuncture on 6-hydroxydopamine-induced nigrostratal dopaminergic neuronal cell death in rats.
    Kim YK, Lim HH, Song YK, Lee HH, Lim S, Han SM, Kim CJ.
    Neurosci Lett; 2005 Sep 01; 384(1-2):133-8. PubMed ID: 15893426
    [Abstract] [Full Text] [Related]

  • 20. Treatment with alpha2-adrenoceptor antagonist, 2-methoxy idazoxan, protects 6-hydroxydopamine-induced Parkinsonian symptoms in rats: neurochemical and behavioral evidence.
    Srinivasan J, Schmidt WJ.
    Behav Brain Res; 2004 Oct 05; 154(2):353-63. PubMed ID: 15313023
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.